Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma

Abstract

Although this regimen is feasible, there was significant preoperative toxicity and perioperative mortality. Nonetheless, the recurrence free and overall survival rates were encouraging. However, no staging tool can predict a pathologic complete response after induction therapy accurately, suggesting a continued need for surgical resection.